Aerospace carried, put on a new coat of polysaccharides for probiotics

Data shows that the intestinal industry has a trillion-level market with broad prospects. In recent years, basic and clinical research around the intestinal tract has blossomed everywhere, and it has become one of the most popular scientific topics. This has also attracted more companies to increase investment in the industry and further stimulated the vigorous rise of intestinal flora research. . On May 29, at the China Intestinal Industry Conference held at the same time as the 2021 China Intestinal Conference, the release of the research results of the new generation of manned spacecraft and the launch of the three clinical research projects of probiotics was held. China Resources Jiangzhong, together with Ketuo Biology, China Academy of Space Technology, and Aerospace Shenzhou Biotechnology, jointly carried out the results of probiotics space-carrying experimental research. At the meeting, the space-carrying strains were launched in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. A clinical study of Lactobacillus rhamnosus R7970 regulating the intestinal-renal axis and delaying the progression of kidney disease". The purpose of the probiotics space loading is to screen out strains with better development and utilization value for fermented milk production and probiotic preparations, which will be used for the development of probiotics and fermented dairy products, and further lay the foundation for the industrial development of probiotics. Lu Xiaoqing, general manager of China Resources Jiangzhong, Zhang Heping, distinguished professor of "Changjiang Scholars", Yao Ying, director of the Nutrition Department of Tongji Hospital, Liu Xiaojun, president of Ketuo Bio, and Dr. Liu Wenjun, general manager of China Resources Jiangzhong's R&D department, witnessed this exciting moment at the scene. "Lactobacillus rhamnosus R7970", its number represents that it has conducted space experiments at an altitude of 7,970 kilometers from the ground, and it was China Resources River that sent this strain to space. 　　Dr. Liu Wenjun introduced that on May 5, 2020, a new generation of manned spacecraft was successfully launched. Among them, 3 strains of probiotics screened in China Resources River were carried to the space to participate in related experiments. Gravity, high-energy particle radiation and other complex environments are induced to produce probiotic strains with better properties. 　　At present, China Resources Jiangzhong and Ketuo Biosciences have carried out a one-year research on the fermentation and probiotic characteristics of spaceborne strains, genomics and metabolomics, and strive to incorporate the most cutting-edge aerospace technology into probiotic products. The results of the study show that the probiotic strains that have been carried by the spacecraft, in order to adapt to the space environment, produce immunologically active capsular polysaccharides outside the cell membrane. It is precisely because of the production of this "sugar coating" that the strains are more stable and are fermenting. The process has a higher number of viable bacteria. Professor Zhang Heping proposed that the application prospects of probiotics carried by spaceflight are very broad. 　　In fact, this is not the first time that China Resources Jiangzhong has "linked" with China Aerospace. Earlier, representative products such as Shenlingcao in the China Resources River were carried into space by the Shenzhou spacecraft to protect the health of astronauts. The selection of aerospace food is very strict, and the products of China Resources Jiangzhong can be selected, which is closely related to its focus on scientific research and innovation. 　　China Resources Jiangzhong’s Jiangzhong brand Jianweixiaoshi tablets and Lihuo brand lactic acid bacteria tablets all use modern science and technology to achieve ultimate innovation. Once the products are put on the market, they have been unanimously recognized by consumers. 　　For a long time, China Resources Jiangzhong has been positioned as an "expert and leader in daily gastrointestinal medications. " Therefore, in order to better protect the intestinal health of Chinese people, it produces more products suitable for Chinese people’s intestinal tract. In August last year, “Chinese people’s intestinal health” The Research Institute was officially inaugurated and established in China Resources Jiangzhongjiang Chinese Medicine Valley. The National Institute of Intestinal Health plans to develop a "microbial strain resource library based on the development of live bacteria drugs", which will screen strains suitable for the intestines of Chinese people, lay the foundation for future development of live bacteria drugs, and provide solutions to intestinal problems belonging to the people Create a new highland for probiotic research in China. 　　At this China Intestinal Conference, China Resources Jiangzhong also took the lead in putting forward the strategy of "food as medicine", combining the advantages of traditional Chinese medicine, actively expanding the track in the micro-ecological field, and taking "Chinese medicine+" as a foothold, through independent R&D and external cooperation to expand intestinal treatment products and health products, enrich the product matrix, enhance product efficacy, and continue to improve product strength. 　　In addition, China Resources Jiangzhong also signed a strategic cooperation framework agreement with Northeast Agricultural University to establish strategic partnerships in technology and product research and development, transformation of scientific and technological achievements, and personnel training. 　　Innovation is the soul of an enterprise, and scientific research is the core competitiveness and strongest vitality of an enterprise. 　　After more than 50 years, China Resources Jiangzhong has focused on building core key technologies and competitive advantages in scientific research. Develop functional gastrointestinal disease products based on Jiangzhong’s “home standing”, “digestive medicine” and traditional Chinese medicine “prevention of disease”. Focus on general health, develop innovative medicines, focus on the declaration of new functions of gastrointestinal traditional Chinese medicine and folklore, take the development of new traditional Chinese medicines as the foundation, deploy biological medicines of live bacteria medicines, and enrich the characteristic product system. Focus on solid preparation molding technology, flavor correction technology and evidence-based evaluation technology to consolidate core technologies. 　　This time, China Resources Jiangzhong strives to integrate the most cutting-edge aerospace technology into the research of probiotic products, which broadens the depth and breadth of the research on probiotic strains. 　　In the future, China Resources Jiangzhong will establish a symbiotic R&D organization with top domestic R&D institutions through strategic cooperation, platform co-construction, project promotion, etc. , and build an integrated cooperation mechanism of “industry, learning, and research” to deeply cultivate gastrointestinal and intestinal micro-organisms. In the ecological field, contribute to the development of the industry and escort the health of consumers.   Disclaimer: This article only represents the author's personal views and has nothing to do with China Probiotics. com. The originality and the text and content stated in the article have not been verified by this site. This site does not make any guarantee or commitment to the authenticity, completeness, and timeliness of this article, all or part of the content, and the text. Please readers for reference only, and please Verify the relevant content yourself.   Copyright Notice 1. Some of the reprinted articles on this site are not original, and the copyright and liability belong to the original author. 2. All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and clearly indicate the source and author. Media or individuals who do not want to be reprinted can contact us for infringement information that can provide sufficient evidence , Bio149 will be deleted within 12 hours after confirmation. 3. Users are welcome to post original articles to 86371366@qq. com, and publish them to the homepage after review. The copyright and liability belong to the sender.

Data shows that the intestinal industry has a trillion-level market with broad prospects.
In recent years, basic and clinical research around the intestinal tract has blossomed everywhere, and it has become one of the most popular scientific topics.
This has also attracted more companies to increase investment in the industry and further stimulated the vigorous rise of intestinal flora research.
.


　　On May 29, at the China Intestinal Industry Conference held at the same time as the 2021 China Intestinal Conference, the release of the research results of the new generation of manned spacecraft experimental ship strains and the launch ceremony of 3 clinical research projects of probiotics were held.
China Resources Jiangzhong, China Academy of Space Technology, and Aerospace Shenzhou Biotechnology jointly carried out the results of the probiotic space-carrying experimental research results.
At the meeting, the space-carrying strains were launched in the Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology.
A clinical study of Lactobacillus rhamnosus R7970 regulating the intestinal-renal axis and delaying the progression of kidney disease".


　　The purpose of the probiotics space loading is to screen out strains with better development and utilization value for fermented milk production and probiotic preparations, which will be used for the development of probiotics and fermented dairy products, and further lay the foundation for the industrial development of probiotics.


　　Lu Xiaoqing, general manager of China Resources Jiangzhong, Zhang Heping, distinguished professor of "Changjiang Scholars", Yao Ying, director of the Nutrition Department of Tongji Hospital, Liu Xiaojun, president of Ketuo Bio, and Dr.
Liu Wenjun, general manager of China Resources Jiangzhong's R&D department, witnessed this exciting moment at the scene.


　　"Lactobacillus rhamnosus R7970", its number represents that it has conducted space experiments at an altitude of 7,970 kilometers from the ground, and it was China Resources River that sent this strain to space.


　　Dr.
Liu Wenjun introduced that on May 5, 2020, a new generation of manned spacecraft was successfully launched.
Among them, 3 strains of probiotics screened in China Resources River were carried to the space to participate in related experiments.
Gravity, high-energy particle radiation and other complex environments are induced to produce probiotic strains with better properties.


　　At present, China Resources Jiangzhong and Ketuo Biosciences have carried out a one-year research on the fermentation and probiotic characteristics of spaceborne strains, genomics and metabolomics, and strive to incorporate the most cutting-edge aerospace technology into probiotic products.
The results of the study show that the probiotic strains that have been carried by the spacecraft, in order to adapt to the space environment, produce immunologically active capsular polysaccharides outside the cell membrane.
It is precisely because of the production of this "sugar coating" that the strains are more stable and are fermenting.
The process has a higher number of viable bacteria.
Professor Zhang Heping proposed that the application prospects of probiotics carried by spaceflight are very broad.


　　In fact, this is not the first time that China Resources Jiangzhong has "linked" with China Aerospace.
Earlier, representative products such as Shenlingcao in the China Resources River were carried into space by the Shenzhou spacecraft to protect the health of astronauts.
The selection of aerospace food is very strict, and the products of China Resources Jiangzhong can be selected, which is closely related to its focus on scientific research and innovation.


　　China Resources Jiangzhong’s Jiangzhong brand Jianweixiaoshi tablets and Lihuo brand lactic acid bacteria tablets all use modern science and technology to achieve ultimate innovation.
Once the products are put on the market, they have been unanimously recognized by consumers.


　　For a long time, China Resources Jiangzhong has been positioned as an "expert and leader in daily gastrointestinal medications.
" Therefore, in order to better protect the intestinal health of Chinese people, it produces more products suitable for Chinese people’s intestinal tract.
In August last year, “Chinese people’s intestinal health” The Research Institute was officially inaugurated and established in China Resources Jiangzhongjiang Chinese Medicine Valley.
The National Institute of Intestinal Health plans to develop a "microbial strain resource library based on the development of live bacteria drugs", which will screen strains suitable for the intestines of Chinese people, lay the foundation for future development of live bacteria drugs, and provide solutions to intestinal problems belonging to the people Create a new highland for probiotic research in China.


　　At this China Intestinal Conference, China Resources Jiangzhong also took the lead in putting forward the strategy of "food as medicine", combining the advantages of traditional Chinese medicine, actively expanding the track in the micro-ecological field, and taking "Chinese medicine+" as a foothold, through independent R&D and external cooperation to expand intestinal treatment products and health products, enrich the product matrix, enhance product efficacy, and continue to improve product strength.


　　In addition, China Resources Jiangzhong also signed a strategic cooperation framework agreement with Northeast Agricultural University to establish strategic partnerships in technology and product research and development, transformation of scientific and technological achievements, and personnel training.


　　Innovation is the soul of an enterprise, and scientific research is the core competitiveness and strongest vitality of an enterprise.


　　After more than 50 years, China Resources Jiangzhong has focused on building core key technologies and competitive advantages in scientific research.
Develop functional gastrointestinal disease products based on Jiangzhong’s “home standing”, “digestive medicine” and traditional Chinese medicine “prevention of disease”.
Focus on general health, develop innovative medicines, focus on the declaration of new functions of gastrointestinal traditional Chinese medicine and folklore, take the development of new traditional Chinese medicines as the foundation, deploy biological medicines of live bacteria medicines, and enrich the characteristic product system.
Focus on solid preparation molding technology, flavor correction technology and evidence-based evaluation technology to consolidate core technologies.


　　This time, China Resources Jiangzhong strives to integrate the most cutting-edge aerospace technology into the research of probiotic products, which broadens the depth and breadth of the research on probiotic strains.


　　In the future, China Resources Jiangzhong will establish a symbiotic R&D organization with top domestic R&D institutions through strategic cooperation, platform co-construction, project promotion, etc.
, and build an integrated cooperation mechanism of “industry, learning, and research” to deeply cultivate gastrointestinal and intestinal micro-organisms.
In the ecological field, contribute to the development of the industry and escort the health of consumers.

---

Data shows that the intestinal industry has a trillion-level market with broad prospects.
In recent years, basic and clinical research around the intestinal tract has blossomed everywhere, and it has become one of the most popular scientific topics.
This has also attracted more companies to increase investment in the industry and further stimulated the vigorous rise of intestinal flora research.
.


　　On May 29, at the China Intestinal Industry Conference held at the same time as the 2021 China Intestinal Conference, the release of the research results of the new generation of manned spacecraft experimental ship strains and the launch ceremony of 3 clinical research projects of probiotics were held.
China Resources Jiangzhong, together with Ketuo Biology, China Academy of Space Technology, and Aerospace Shenzhou Biotechnology, jointly carried out the results of probiotics space-carrying experimental research.
At the meeting, the space-carrying strains were launched in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
A clinical study of Lactobacillus rhamnosus R7970 regulating the intestinal-renal axis and delaying the progression of kidney disease".


　　The purpose of the probiotics space loading is to screen out strains with better development and utilization value for fermented milk production and probiotic preparations, which will be used for the development of probiotics and fermented dairy products, and further lay the foundation for the industrial development of probiotics.


　　Lu Xiaoqing, general manager of China Resources Jiangzhong, Zhang Heping, distinguished professor of "Changjiang Scholars", Yao Ying, director of the Nutrition Department of Tongji Hospital, Liu Xiaojun, president of Ketuo Bio, and Dr.
Liu Wenjun, general manager of China Resources Jiangzhong's R&D department, witnessed this exciting moment at the scene.


　　"Lactobacillus rhamnosus R7970", its number represents that it has conducted space experiments at an altitude of 7,970 kilometers from the ground, and it was China Resources River that sent this strain to space.


　　Dr.
Liu Wenjun introduced that on May 5, 2020, a new generation of manned spacecraft was successfully launched.
Among them, 3 strains of probiotics screened in China Resources River were carried to the space to participate in related experiments.
Gravity, high-energy particle radiation and other complex environments are induced to produce probiotic strains with better properties.


　　At present, China Resources Jiangzhong and Ketuo Biosciences have carried out a one-year research on the fermentation and probiotic characteristics of spaceborne strains, genomics and metabolomics, and strive to incorporate the most cutting-edge aerospace technology into probiotic products.
The results of the study show that the probiotic strains that have been carried by the spacecraft, in order to adapt to the space environment, produce immunologically active capsular polysaccharides outside the cell membrane.
It is precisely because of the production of this "sugar coating" that the strains are more stable and are fermenting.
The process has a higher number of viable bacteria.
Professor Zhang Heping proposed that the application prospects of probiotics carried by spaceflight are very broad.


　　In fact, this is not the first time that China Resources Jiangzhong has "linked" with China Aerospace.
Earlier, representative products such as Shenlingcao in the China Resources River were carried into space by the Shenzhou spacecraft to protect the health of astronauts.
The selection of aerospace food is very strict, and the products of China Resources Jiangzhong can be selected, which is closely related to its focus on scientific research and innovation.


　　China Resources Jiangzhong’s Jiangzhong brand Jianweixiaoshi tablets and Lihuo brand lactic acid bacteria tablets all use modern science and technology to achieve ultimate innovation.
Once the products are put on the market, they have been unanimously recognized by consumers.


　　For a long time, China Resources Jiangzhong has been positioned as an "expert and leader in daily gastrointestinal medications.
" Therefore, in order to better protect the intestinal health of Chinese people, it produces more products suitable for Chinese people’s intestinal tract.
In August last year, “Chinese people’s intestinal health” The Research Institute was officially inaugurated and established in China Resources Jiangzhongjiang Chinese Medicine Valley.
The National Institute of Intestinal Health plans to develop a "microbial strain resource library based on the development of live bacteria drugs", which will screen strains suitable for the intestines of Chinese people, lay the foundation for future development of live bacteria drugs, and provide solutions to intestinal problems belonging to the people Create a new highland for probiotic research in China.


　　At this China Intestinal Conference, China Resources Jiangzhong also took the lead in putting forward the strategy of "food as medicine", combining the advantages of traditional Chinese medicine, actively expanding the track in the micro-ecological field, and taking "Chinese medicine+" as a foothold, through independent R&D and external cooperation to expand intestinal treatment products and health products, enrich the product matrix, enhance product efficacy, and continue to improve product strength.


　　In addition, China Resources Jiangzhong also signed a strategic cooperation framework agreement with Northeast Agricultural University to establish strategic partnerships in technology and product research and development, transformation of scientific and technological achievements, and personnel training.


　　Innovation is the soul of an enterprise, and scientific research is the core competitiveness and strongest vitality of an enterprise.


　　After more than 50 years, China Resources Jiangzhong has focused on building core key technologies and competitive advantages in scientific research.
Develop functional gastrointestinal disease products based on Jiangzhong’s “home standing”, “digestive medicine” and traditional Chinese medicine “prevention of disease”.
Focus on general health, develop innovative medicines, focus on the declaration of new functions of gastrointestinal traditional Chinese medicine and folklore, take the development of new traditional Chinese medicines as the foundation, deploy biological medicines of live bacteria medicines, and enrich the characteristic product system.
Focus on solid preparation molding technology, flavor correction technology and evidence-based evaluation technology to consolidate core technologies.


　　This time, China Resources Jiangzhong strives to integrate the most cutting-edge aerospace technology into the research of probiotic products, which broadens the depth and breadth of the research on probiotic strains.


　　In the future, China Resources Jiangzhong will establish a symbiotic R&D organization with top domestic R&D institutions through strategic cooperation, platform co-construction, project promotion, etc.
, and build an integrated cooperation mechanism of “industry, learning, and research” to deeply cultivate gastrointestinal and intestinal micro-organisms.
In the ecological field, contribute to the development of the industry and escort the health of consumers.

---

---